Logo image of CRESY

CRESUD S.A.-SPONS ADR (CRESY) Stock Fundamental Analysis

NASDAQ:CRESY - Nasdaq - US2264061068 - ADR - Currency: USD

12.39  +0.43 (+3.6%)

Fundamental Rating

2

Taking everything into account, CRESY scores 2 out of 10 in our fundamental rating. CRESY was compared to 88 industry peers in the Food Products industry. CRESY may be in some trouble as it scores bad on both profitability and health. CRESY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

Of the past 5 years CRESY 4 years were profitable.
CRESY had a positive operating cash flow in 4 of the past 5 years.
CRESY Yearly Net Income VS EBIT VS OCF VS FCFCRESY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200B -400B

1.2 Ratios

With a Return On Assets value of -1.21%, CRESY is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
The Return On Equity of CRESY (-6.46%) is worse than 64.77% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.46%, CRESY is in line with its industry, outperforming 44.32% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRESY is significantly below the industry average of 9.00%.
The 3 year average ROIC (2.55%) for CRESY is below the current ROIC(3.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.21%
ROE -6.46%
ROIC 3.46%
ROA(3y)4.46%
ROA(5y)1.27%
ROE(3y)25.84%
ROE(5y)3.92%
ROIC(3y)2.55%
ROIC(5y)1.98%
CRESY Yearly ROA, ROE, ROICCRESY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 16.50%, CRESY belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
CRESY's Operating Margin has been stable in the last couple of years.
CRESY has a better Gross Margin (34.19%) than 73.86% of its industry peers.
In the last couple of years the Gross Margin of CRESY has declined.
Industry RankSector Rank
OM 16.5%
PM (TTM) N/A
GM 34.19%
OM growth 3Y103.59%
OM growth 5Y-0.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.68%
GM growth 5Y-1.65%
CRESY Yearly Profit, Operating, Gross MarginsCRESY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

More info and screens

2

2. Health

2.1 Basic Checks

CRESY has less shares outstanding than it did 1 year ago.
CRESY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRESY has been reduced compared to a year ago.
CRESY Yearly Shares OutstandingCRESY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRESY Yearly Total Debt VS Total AssetsCRESY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1T 2T 3T

2.2 Solvency

A Debt/Equity ratio of 0.95 indicates that CRESY is somewhat dependend on debt financing.
CRESY's Debt to Equity ratio of 0.95 is on the low side compared to the rest of the industry. CRESY is outperformed by 71.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CRESY Yearly LT Debt VS Equity VS FCFCRESY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200B -200B 400B -400B 600B

2.3 Liquidity

CRESY has a Current Ratio of 1.05. This is a normal value and indicates that CRESY is financially healthy and should not expect problems in meeting its short term obligations.
CRESY has a worse Current ratio (1.05) than 68.18% of its industry peers.
CRESY has a Quick Ratio of 1.05. This is a bad value and indicates that CRESY is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.79, CRESY is in line with its industry, outperforming 44.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.79
CRESY Yearly Current Assets VS Current LiabilitesCRESY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CRESY have decreased strongly by -135.27% in the last year.
Looking at the last year, CRESY shows a very strong growth in Revenue. The Revenue has grown by 37.65%.
Measured over the past years, CRESY shows a very strong growth in Revenue. The Revenue has been growing by 71.80% on average per year.
EPS 1Y (TTM)-135.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.55%
Revenue 1Y (TTM)37.65%
Revenue growth 3Y68.04%
Revenue growth 5Y71.8%
Sales Q2Q%-0.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRESY Yearly Revenue VS EstimatesCRESY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CRESY Price Earnings VS Forward Price EarningsCRESY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRESY Per share dataCRESY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRESY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (4/17/2025, 8:10:52 PM)

12.39

+0.43 (+3.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-06 2025-02-06
Earnings (Next)05-08 2025-05-08
Inst Owners14.26%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap741.00M
Analysts86.67
Price TargetN/A
Short Float %1.84%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-184.35%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.21%
ROE -6.46%
ROCE 4.38%
ROIC 3.46%
ROICexc 3.84%
ROICexgc 3.94%
OM 16.5%
PM (TTM) N/A
GM 34.19%
FCFM N/A
ROA(3y)4.46%
ROA(5y)1.27%
ROE(3y)25.84%
ROE(5y)3.92%
ROIC(3y)2.55%
ROIC(5y)1.98%
ROICexc(3y)2.84%
ROICexc(5y)2.27%
ROICexgc(3y)2.9%
ROICexgc(5y)2.34%
ROCE(3y)3.23%
ROCE(5y)2.51%
ROICexcg growth 3Y84.33%
ROICexcg growth 5Y19.28%
ROICexc growth 3Y83.34%
ROICexc growth 5Y20.03%
OM growth 3Y103.59%
OM growth 5Y-0.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.68%
GM growth 5Y-1.65%
F-Score2
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA 4.64
Cap/Depr 479.66%
Cap/Sales 8.33%
Interest Coverage 1.04
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.79
Altman-Z N/A
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)595.85%
Cap/Depr(5y)423.1%
Cap/Sales(3y)8.46%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.65%
Revenue growth 3Y68.04%
Revenue growth 5Y71.8%
Sales Q2Q%-0.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.79%
EBIT growth 3Y242.1%
EBIT growth 5Y70.1%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23131.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-445.11%
OCF growth 3YN/A
OCF growth 5Y5.31%